Iron Dextran Articles
Watson swings to profit of $38.4M in 4th qtr
3 March 2008
Q-Med launches Cosmofer in Sweden
17 July 2006
Schein distributes newly-made INFeD
7 April 1999
Ferrlecit appro a fillip for Schein after INFeD woes
22 February 1999
Schein Pharmaceutical resume shipping of INFeD
5 November 1998
Schein In Agreement With FDA Over Steris
19 October 1998
Smaller US Firms' Losses Grow Due To R&D Costs
31 July 1997
Will The Fisons Medeva Marriage Take Place?
10 July 1995
Schein Approval
27 March 1995
Bayer And Schein Reinforce Generics Presence
10 October 1994
FISONS CEASES MANUFACTURE OF IMFERON
15 February 1993
UK FIRMS BOOSTED BY YEAR-END US APPROVALS
4 January 1993
LONDON STOCK COMMENT
14 December 1992
FISONS DIVESTS TO FOCUS ON PHARMACEUTICALS
11 May 1992
FISONS RE-LICENSED FOR OPTICROM
3 February 1992
NO END TO FISONS' PROBLEMS?
27 January 1992
SHOCK RESIGNATION OF FISONS' CHAIRMAN
20 January 1992
Showing 1-18 of 18 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
